Consensus DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 05:00:00 07/11/2026 HKT			5-day change	1st Jan Change
79.41 ^USD	-5.98%		-3.50%	+19.65%

10-31	DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says	MT
10-30	UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating	MT

Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

b31e909fc9c07aac.zxxXS8maPsw-vNRlkbC3KQpOFRqjVS0dkUxoxJzZw4E.p3sCMqH-Sp1L0oEo1sLBcW8jZ1_TeGIqpylRp7H0otX_eB49_flq4XvZnQ~85a44ba852e7a395831194493b876476

Analysts' recommendations: DexCom, Inc.

10-31	DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says	MT
10-30	UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating	MT
10-30	Raymond James Adjusts Price Target on DexCom to $97 From $94	MT
10-30	Barclays Adjusts Price Target on DexCom to $120 From $115	MT
10-26	Leerink Partners Adjusts Price Target on DexCom to $87 From $94	MT
10-13	Mizuho Adjusts Price Target on DexCom to $100 From $95	MT
10-12	BTIG Adjusts Price Target on DexCom to $96 From $90	MT
10-07	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08-03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
08-01	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
07-31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
07-31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
07-31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
07-31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
07-31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
07-31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
07-31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
07-31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
07-31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
07-31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DEXCOM, INC.					+23.6%
	ABBOTT LABORATORIES					+7.82%
	MEDTRONIC PLC					+2.77%
	STRYKER CORPORATION					+4.48%
	ESSILORLUXOTTICA					+11.41%
	CENCORA, INC.					+11.8%
	BECTON, DICKINSON AND COMPANY					-7.7%
	IDEXX LABORATORIES, INC.					+6.08%
	HOYA CORPORATION					+36.89%
	ALCON INC.					+20.39%
	Average					+11.75%
	Weighted average by Cap.					+8.87%